| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 06/04/2002 | US6399369 Multipotent neural stem cell cDNA libraries |
| 06/04/2002 | US6399341 Artificial pancreas |
| 06/04/2002 | US6399300 Recombinant embryonic cardiomyocyte cell having two constructs which are selectable marker genes under control of separate promoters; gene therapy; drug screening |
| 06/04/2002 | US6399105 Lipoxygenase inhibitors for inflammatory autoimmune diseases |
| 06/04/2002 | US6399070 Heat shock protein complex for immunology |
| 06/04/2002 | US6399069 Purification and prevention of disease with heat shock protein bound to antigens |
| 06/04/2002 | US6399067 Methods and compositions for impairing multiplication of HIV-1 |
| 06/04/2002 | US6399058 Methods for treating ocular diseases |
| 06/04/2002 | US6399055 Method and composition for treatment of infant diarrhea |
| 06/04/2002 | US6399054 Mhc restricted, tumor-specific t cells; incubating with ternary complex of biotinylated antibody against cell surface antigen, an avidin, streptavidin or neutravidin ligand, and biotinylated b7-ig, co-cultivating tumor cells with t cells |
| 06/04/2002 | US6398972 Placing blood in a rigid sterilization container and centrifuging to separate erythrocytes and the resulting blood supernatant, then decanting |
| 06/04/2002 | CA2361950A1 Antibiotics g 23077, pharmaceutically acceptable salts and compositions, and use thereof |
| 06/04/2002 | CA2119262C Compositions comprising a bactericidal/permeability increasing protein and a lipid carrier, methods of making same, and uses thereof |
| 05/30/2002 | WO2002042455A2 Modifier of organelle metalbolism |
| 05/30/2002 | WO2002042445A2 Differentiated cells suitable for human therapy |
| 05/30/2002 | WO2002042433A1 Method of amplifying natural killer cells shifting into th2 or th1 type |
| 05/30/2002 | WO2002042328A2 Method for studying the effects of commensal microflora on mammalian intestine and treatments of gastrointestinal-associated disease based thereon |
| 05/30/2002 | WO2002022648A3 Compositions and methods for inducing specific cytolytic t cell responses |
| 05/30/2002 | WO2002018441A3 Electroprocessed fibrin-based matrices and tissues |
| 05/30/2002 | WO2002017980A3 Methods and compositions for tissue regeneration |
| 05/30/2002 | WO2002012444A3 Amniotic apoptosis modulating substances |
| 05/30/2002 | WO2002011785A3 Manipulation of arterial-venous identity |
| 05/30/2002 | WO2002010346A3 Insulin producing cell-line obtained by electrofusion |
| 05/30/2002 | WO2001098482A3 Liver-specific gene expression cassettes, and methods of use |
| 05/30/2002 | WO2001091789A3 Combination of a mutant herpes virus and a chemotherapeutic agent for the treatment of cancer |
| 05/30/2002 | WO2001089539A3 Methods for restoring or enhancing t-cell immune surveillance following naturally or artifically induced immunosuppression |
| 05/30/2002 | WO2001087934A3 Treatment of neoplasia/transformation using a pituitary tumor transforming gene carboxy terminal peptides |
| 05/30/2002 | WO2001073094A3 Novel sperm-dna complexes for genetically modifying non-human animals |
| 05/30/2002 | WO2001068888A3 Production of chimeric capsid vectors |
| 05/30/2002 | WO2001068814A3 Multipotent cell and cardiomyocyte cell populations, and routes to and uses of same |
| 05/30/2002 | WO2001048187A3 A molecular switch for regulating mammalian gene expression |
| 05/30/2002 | WO2001031058A3 Identification of cells for transplantation |
| 05/30/2002 | US20020065395 Polypeptide for use as diagnostic tool in screening bactericides |
| 05/30/2002 | US20020065241 A recombinant polynucleotide of first polynucleotides coding an antigenic peptide and are operatively linked to each other to enhance translation of the polynucleotides to the peptides and binding to MHC; cancer vaccine |
| 05/30/2002 | US20020065231 Method for producing biologically active products |
| 05/30/2002 | US20020065217 Treatments which elevate functional glycosylated leptin transport factor, for controlling weight and obesity |
| 05/30/2002 | US20020065212 Methods of treating disease using sertoli cells and allografts or xenografts |
| 05/30/2002 | US20020064877 Methods of producing and using a human microglial cell line |
| 05/30/2002 | US20020064873 Stable neural stem cell lines |
| 05/30/2002 | US20020064862 Preventing viral replication in cells; obtain cells, incubate with viricide, monitor cells for reduced viral activity |
| 05/30/2002 | US20020064859 Nuclelotide sequences coding heterologous protein for use in the treatment of cancer, infections, genetic and immunological disorder |
| 05/30/2002 | US20020064823 Nucleotide sequences which code binding protein for use in human therapeutics and gene therapy |
| 05/30/2002 | US20020064812 Plasmid for use in the treatment of blood disorders |
| 05/30/2002 | US20020064786 Cancer diagnosis and therapy based on mutations in TGF-beta receptors |
| 05/30/2002 | US20020064568 Product and method for treating joint disorders in vertebrates |
| 05/30/2002 | US20020064553 Large liposome composition not increasing ldl levels and method of treating atherosclerosis related thereto |
| 05/30/2002 | US20020064538 Using a compound that inhibits or induces expression of tropoelastin mRNA or protein in keratinocytes; prevents photoaging |
| 05/30/2002 | US20020064536 Immobilizing a mammal by administering the toxin with a polysaccharide stabilizer, nonimmunogenic; use after surgery such as hip displasia or to recover from leg injuries in domestic animals |
| 05/30/2002 | US20020064522 Activated hemicellulose as active ingredient; use as anticancer agents |
| 05/30/2002 | US20020064520 Targeted artificial gene delivery |
| 05/30/2002 | US20020064519 Administering non-autologous (allogeneic) mesenchymal stem cells (they are "invisible" to the immune system) to promote hematopoietic or progenitor cell engraftment; use as host cells in gene therapy or in tissue repair |
| 05/30/2002 | US20020064518 Fermented product produced by adding a manganese-containing natural material (e.g. tea) and fermenting with bacteria having catalase activity |
| 05/30/2002 | CA2434760A1 Differentiated cells suitable for human therapy |
| 05/29/2002 | EP1208952A2 Guard and control apparatuses for sliding compound mitre saw |
| 05/29/2002 | EP1208380A2 Cancer associated antigens and uses therefor |
| 05/29/2002 | EP1208235A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 05/29/2002 | EP1208228A2 Differential gene expression in specific regions of the brain in neurodegenerative diseases |
| 05/29/2002 | EP1208218A2 Methods and compositions for delivery of pharmaceutical agents |
| 05/29/2002 | EP1208217A1 Antibody dependent enhancement (ade) of alphavirus infection |
| 05/29/2002 | EP1208212A1 Fibrin sealant as a transfection/transformation vehicle for gene therapy |
| 05/29/2002 | EP1208198A2 Egfh2 genes and gene products |
| 05/29/2002 | EP1207892A1 Use of oyster flesh enzymatic hydrolysates for preparing compositions eliminating free radicals |
| 05/29/2002 | EP1207859A1 Oral form of administration containing probiotic micro-organisms |
| 05/29/2002 | EP1207848A1 Purifying and/or regenerating agent |
| 05/29/2002 | EP0826311B1 Oral composition for animals |
| 05/29/2002 | EP0752002B1 Inhibition of arterial smooth muscle cell proliferation |
| 05/29/2002 | EP0613374B1 Lactobacillus and skim milk compositions and methods for preventing microbial urogenital infections |
| 05/29/2002 | CN1351656A Human liver progenitors |
| 05/29/2002 | CN1351653A Anti-bacterial vaccine compositions |
| 05/29/2002 | CN1351503A Vaccine against streptococcus pneumoniae |
| 05/29/2002 | CN1351501A Vaccine against antigens from bacteriae |
| 05/29/2002 | CN1351500A Method for preparing dual virally inactivated immune globulin for intravenous administration |
| 05/29/2002 | CN1351484A Compositions for freezing dog sperm, method of freezing the dog sperm utilizing the compositions and artificial insemination method employing the frozen dog sperm |
| 05/29/2002 | CN1351473A Composition |
| 05/29/2002 | CN1351471A Heath-care food for joints of pet |
| 05/29/2002 | CN1350867A Compound oyster shell liquid |
| 05/29/2002 | CN1350857A Face-beautifying ointment and its preparing process |
| 05/29/2002 | CN1350856A Ointment for treating gastrosis by fomentation |
| 05/29/2002 | CN1350854A Full-natural medicine for treating calculus |
| 05/29/2002 | CN1350850A Soft capsule of superfine compound pearl powder and its preparing process |
| 05/29/2002 | CN1085550C Medicine for rheumatism and its preparation |
| 05/29/2002 | CN1085549C Medicinal liquor for treating hyperlipemia and hyperviscosity blood |
| 05/29/2002 | CN1085547C Chinese medicine for treating proliferation of mammary gland |
| 05/29/2002 | CN1085543C Oral liquid for treating stomach disease |
| 05/29/2002 | CN1085538C Chinese medicine for curing gastric cancer and esophagus cancer |
| 05/29/2002 | CN1085537C Hog cholera treating medicine |
| 05/29/2002 | CN1085533C Pilose antler-wood trog oil oral liquor and preparing method thereof |
| 05/29/2002 | CN1085532C Medicine for giving up medicinal dependence |
| 05/29/2002 | CN1085531C Preparation for protecting liver and relieving acute alcoholism and its preparing method |
| 05/29/2002 | CN1085530C External use medicine for treating open wound |
| 05/28/2002 | US6395546 Generation of dopaminergic neurons from human nervous system stem cells |
| 05/28/2002 | US6395542 Exposing immortalized intestinal tract cells, with an agent that does not express tumor markers, and expresses metabolic markers and is capable of adhering in vitro to a lactic acid strain of bacterium; determine mutagenic, toxic effects |
| 05/28/2002 | US6395519 Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer |
| 05/28/2002 | US6395513 Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 05/28/2002 | US6395277 Method and compositions for the treatment of cerebral palsy |
| 05/28/2002 | US6395271 Culturing myecelial inoculum in potato dextrose broth, then harvesting when culture at specific redness index; antitumor agents; anticarcinogenic agents |
| 05/28/2002 | US6394812 Vivo induction for enhanced function of isolated hepatocytes |
| 05/23/2002 | WO2002040678A1 Small acid-soluble spore protein and uses thereof |
| 05/23/2002 | WO2002040648A1 T cell line and use thereof |
| 05/23/2002 | WO2002040646A1 Generation and use of dendritic cells |